CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
|   | 1 | Mainly Alpha | 
|   | 1.10 | Orthogonal Bundle | 
|   | 1.10.510 | Transferase(Phosphotransferase); domain 1 | 
|   | 1.10.510.10 | Transferase(Phosphotransferase) domain 1 | 
Domain Context
CATH Clusters
| Superfamily | Transferase(Phosphotransferase) domain 1 | 
| Functional Family | Mitogen-activated protein kinase 14 | 
Enzyme Information
| 2.7.11.24 | Mitogen-activated protein kinase. based on mapping to UniProt Q16539 ATP + a protein = ADP + a phosphoprotein. -!- Phosphorylation of specific tyrosine and threonine residues in the activation loop of this enzyme by EC 2.7.12.2 is necessary for enzyme activation. -!- Once activated, the enzyme phosphorylates target substrates on serine or threonine residues followed by a proline. -!- A distinguishing feature of all MAPKs is the conserved sequence Thr- Xaa-Tyr (TXY). -!- Mitogen-activated protein kinase (MAPK) signal transduction pathways are among the most widespread mechanisms of cellular regulation. -!- Mammalian MAPK pathways can be recruited by a wide variety of stimuli including hormones (e.g. insulin and growth hormone), mitogens (e.g. epidermal growth factor and platelet-derived growth factor), vasoactive peptides (e.g. angiotensin-II and endothelin), inflammatory cytokines of the tumor necrosis factor (TNF) family and environmental stresses such as osmotic shock, ionizing radiation and ischemeic injury. -!- Formerly EC 2.7.1.37. | 
UniProtKB Entries (1)
| Q16539 | MK14_HUMAN Homo sapiens Mitogen-activated protein kinase 14 | 
PDB Structure
| PDB | 3FMH | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | |
| Primary Citation | The Discovery of Pamapimod and R1487 as Orally Bioavailable and Highly Selective Inhibitors of p38 Map Kinase To be Published | 
